ACOG-22.55%14.3%
MREO-80.82%14.3%
MTSR-8.49%14.3%
RZLT-2.29%14.3%
SUPN+47.10%14.3%
VERA+74.33%14.3%
VYGR+3.66%14.3%
As of Jul 10, 2026, 7:14 AM ET
Biotech '25: Neurology, CNS & Rare Disorders Constituents
| Company | Wgt | Premarket % | 1D % | 10D % | MTD % | YTD % | IranWar % | LibDay % | 1Yr % | Mkt Cap |
|---|---|---|---|---|---|---|---|---|---|---|
Metsera, Inc.MTSR | 14.3% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 47.04% | -8.49% | $3.51B |
Vera Therapeutics, Inc.VERA | 14.3% | -1.30% | 0.05% | -1.62% | -0.49% | -16.17% | 4.07% | 79.95% | 74.33% | $3.05B |
Supernus Pharmaceuticals, Inc.SUPN | 14.3% | 0.00% | -3.35% | 4.17% | 2.83% | -1.91% | -10.93% | 48.54% | 47.10% | $2.83B |
Rezolute, Inc.RZLT | 14.3% | -0.88% | 3.43% | 0.59% | 3.64% | 117.37% | 59.81% | 69.87% | -2.29% | $494.0M |
Voyager Therapeutics, Inc.VYGR | 14.3% | 1.90% | -1.34% | 2.79% | 2.22% | -6.36% | -10.24% | 7.92% | 3.66% | $222.4M |
Alpha Cognition Inc. Common StockACOG | 14.3% | 0.00% | 0.24% | 25.11% | 9.37% | 31.08% | 42.00% | 67.72% | -22.55% | $132.3M |
Mereo BioPharma Group plcMREO | 14.3% | -4.10% | 2.59% | -2.35% | 0.37% | -22.20% | -12.52% | -86.32% | -80.82% | $51.7M |
| Theme return | — | -0.63% | 0.23% | 4.10% | 2.05% | 16.44% | 11.71% | 109.21% | 56.01% | — |
| Average | 14.3% | -0.63% | 0.23% | 4.10% | 2.56% | 14.54% | 10.31% | 33.53% | 1.56% | $1.47B |
| Median | 14.3% | 0.00% | 0.05% | 0.59% | 2.22% | -1.91% | 0.00% | 48.54% | -2.29% | $494.0M |
| Std Dev | 0.0% | 1.70% | 2.11% | 8.84% | 3.13% | 44.82% | 26.71% | 53.55% | 46.07% | $1.45B |
| Min | 14.3% | -4.10% | -3.35% | -2.35% | -0.49% | -22.20% | -12.52% | -86.32% | -80.82% | $51.7M |
| Max | 14.3% | 1.90% | 3.43% | 25.11% | 9.37% | 117.37% | 59.81% | 79.95% | 74.33% | $3.51B |
| % Positive Tickers | 14.29% | 57.14% | 57.14% | 71.43% | 28.57% | 42.86% | 85.71% | 42.86% |
About this theme
Biotech '25: Neurology, CNS & Rare Disorders tracks 7 publicly listed stocks in this theme: ACOG, MREO, MTSR, RZLT, SUPN, VERA, VYGR. See the constituent table for details.